Study potentially links low blood amylin level to reduced progression of Alzheimer’s disease

More than 5.7 million Americans live with Alzheimer’s disease and that number is projected to triple by 2050. Despite that growing number, there is not yet a cure. Florin Despa, a professor with the University of Kentucky’s Department of Pharmacology and Nutritional Sciences, says, “The mechanisms underlying neurodegenerative diseases are largely unknown and effective therapies […]

Continue Reading